| Becky Durham-flint, P.a. | |
|
105 S Riverside Dr Suite 100 Indialantic FL 32903-4365 | |
| (321) 733-2299 | |
| (321) 733-7515 |
| Full Name | Becky Durham-flint, P.a. |
|---|---|
| Speciality | Community/Behavioral Health |
| Location | 105 S Riverside Dr, Indialantic, Florida |
| Authorized Official Name and Position | Becky T Durham (OWNER) |
| Authorized Official Contact | 3217332299 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Becky Durham-flint, P.a. 105 S Riverside Dr Suite 100 Indialantic FL 32903-4365 Ph: (321) 733-2299 | Becky Durham-flint, P.a. 105 S Riverside Dr Suite 100 Indialantic FL 32903-4365 Ph: (321) 733-2299 |
| NPI Number | 1245552876 |
|---|---|
| Provider Enumeration Date | 02/23/2010 |
| Last Update Date | 02/23/2010 |
| Medicare PECOS PAC ID | 3577607811 |
|---|---|
| Medicare Enrollment ID | O20100224000480 |
News Archive
CSL Behring announced today that the U.S. Food and Drug Administration (FDA) has granted marketing approval for Berinert® C1-Esterase Inhibitor, Human for the treatment of acute abdominal or facial attacks of hereditary angioedema (HAE), a rare and serious genetic disorder, in adult and adolescent patients. Berinert is the first and only therapy approved for this indication in the U.S.
Over the past four years, in the installations of the Faculty of Medicine, University of Cadiz, a group of researchers, headed by Doctor Carmen Estrada, has been studying neurogenesis - the process of forming new neurons from mother cells - in the adult mammal brain. The purpose of this research project is to contribute to the knowledge of this process with the object of finding some additional mechanism that would facilitate the treatment of pathologies of the central nervous system (CNS) that are suffered in consequence of neuronal death.
The "National Institutes of Health - perhaps our best hope for funding a cure for AIDS - has been underfunded since 2003," Kate Krauss, director of the AIDS Policy Project, writes in a Philadelphia Inquirer opinion piece.
While studies over the recent years have contributed to an improved understanding of psoriasis, there are still significant gaps in knowledge related to the epidemiology of this serious, chronic disease and trends in incidence over time. The World Health Organization, reported in 2013 that the worldwide prevalence of psoriasis is around 2%, but that studies in developed countries have declared prevalence rates of more than twice the global estimate at an average of 4.6% .
› Verified 5 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1245552876 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 251S00000X | Community/behavioral Health | 000389 (Florida) | Primary |
| Provider Name | Becky T Durham-flint |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1851328470 PECOS PAC ID: 1456495795 Enrollment ID: I20100224000419 |
News Archive
CSL Behring announced today that the U.S. Food and Drug Administration (FDA) has granted marketing approval for Berinert® C1-Esterase Inhibitor, Human for the treatment of acute abdominal or facial attacks of hereditary angioedema (HAE), a rare and serious genetic disorder, in adult and adolescent patients. Berinert is the first and only therapy approved for this indication in the U.S.
Over the past four years, in the installations of the Faculty of Medicine, University of Cadiz, a group of researchers, headed by Doctor Carmen Estrada, has been studying neurogenesis - the process of forming new neurons from mother cells - in the adult mammal brain. The purpose of this research project is to contribute to the knowledge of this process with the object of finding some additional mechanism that would facilitate the treatment of pathologies of the central nervous system (CNS) that are suffered in consequence of neuronal death.
The "National Institutes of Health - perhaps our best hope for funding a cure for AIDS - has been underfunded since 2003," Kate Krauss, director of the AIDS Policy Project, writes in a Philadelphia Inquirer opinion piece.
While studies over the recent years have contributed to an improved understanding of psoriasis, there are still significant gaps in knowledge related to the epidemiology of this serious, chronic disease and trends in incidence over time. The World Health Organization, reported in 2013 that the worldwide prevalence of psoriasis is around 2%, but that studies in developed countries have declared prevalence rates of more than twice the global estimate at an average of 4.6% .
› Verified 5 days ago
News Archive
CSL Behring announced today that the U.S. Food and Drug Administration (FDA) has granted marketing approval for Berinert® C1-Esterase Inhibitor, Human for the treatment of acute abdominal or facial attacks of hereditary angioedema (HAE), a rare and serious genetic disorder, in adult and adolescent patients. Berinert is the first and only therapy approved for this indication in the U.S.
Over the past four years, in the installations of the Faculty of Medicine, University of Cadiz, a group of researchers, headed by Doctor Carmen Estrada, has been studying neurogenesis - the process of forming new neurons from mother cells - in the adult mammal brain. The purpose of this research project is to contribute to the knowledge of this process with the object of finding some additional mechanism that would facilitate the treatment of pathologies of the central nervous system (CNS) that are suffered in consequence of neuronal death.
The "National Institutes of Health - perhaps our best hope for funding a cure for AIDS - has been underfunded since 2003," Kate Krauss, director of the AIDS Policy Project, writes in a Philadelphia Inquirer opinion piece.
While studies over the recent years have contributed to an improved understanding of psoriasis, there are still significant gaps in knowledge related to the epidemiology of this serious, chronic disease and trends in incidence over time. The World Health Organization, reported in 2013 that the worldwide prevalence of psoriasis is around 2%, but that studies in developed countries have declared prevalence rates of more than twice the global estimate at an average of 4.6% .
› Verified 5 days ago
Aragon Psychological Services, Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 122 4th Ave Ste 200, Indialantic, FL 32903 Phone: 321-327-3793 Fax: 321-327-7914 | |
Andrea G Dertany Psyd Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 105 S Riverside Dr Ste 130, Indialantic, FL 32903 Phone: 321-727-9031 Fax: 321-724-8011 | |
Ocean Breeze Counseling, Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 202 4th Ave, Indialantic, FL 32903 Phone: 321-626-7122 | |
Corinne Zimmer, Psyd Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 107 N Palm Ave, Indialantic, FL 32903 Phone: 321-426-0147 Fax: 321-327-7914 | |
Act Life Transitions, Llc. Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 2965 Limpet Ct, Indialantic, FL 32903 Phone: 321-265-7557 | |
Viera Psychological Services Pa Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 345 6th Ave, Indialantic, FL 32903 Phone: 321-951-2100 Fax: 321-951-1204 |